Robert is CEO, founder, and lead architect of the company’s products, including Capire360 for Cancer and Capire360 for ESRD. He is responsible for team and company leadership.
Robert has over 30-years of experience in developing analytic models for healthcare, professional sports, financial services, and manufacturing. Robert worked as a researcher and consultant at Washington University in St. Louis School of Medicine, where he co-developed models for personalized cancer care, and an adjunct faculty at Washington University’s Olin School of Business Entrepreneurship Program from 2007-2013.
His work has been published in Harvard Health Policy Review and Becker’s Hospital Review. He has received awards and honors from GuideWell Innovation, the American Cancer Society, Predictive Analytics World Conference, and South by Southwest.
Jerry is responsible for the clinical data registries and analytics platforms that power Capire360. He works closely with MyCancerJourney’s team of advocates, ensuring they have all the tools they need to best support members.
Dr. Henderson is a practicing oncologic emergency medicine doctor. He was formerly Chair of both the Informatics Governance and the Inpatient Clinical Informatics Committees at MD Anderson. In his time at MD Anderson, he designed and implemented the Oncologic Emergency Medicine fellowship, the first of its kind in the world, as well as a software program called Zero-G, receiving him the Innovator of the Year Award in 2013.
Dr. Henderson earned his medical degree from Royal College of Surgeons in Ireland, and completed his residency at University of Texas Galveston. He has continued education, earning an MBA from Rice University, and attended the Harvard Business School Executive Education Value Measurement in Healthcare program.
Sal is responsible for all aspects of day-to-day operations, including product delivery, enhancements, and support, as well as the back-office functions of Finance, HR, and Compliance.
Sal brings extensive experience in information technology and business transformation. Sal was a Senior Executive at IBM (most recently the VP of Business Transformation), retiring in 2015. Sal then served as the interim CIO at Florida Blue, focusing on healthcare innovation.
Sal is a member of NACD (National Association of Corporate Directors), and currently serves as an independent director to Peckham Industries and Nuvance Health, where he provides guidance on operational excellence, leveraging technology to transform the business, M&A, cybersecurity and AI, quality, and corporate governance. Mentoring and coaching executives is a personal passion for Sal, and in 2017 he created an Executive Leadership program for the Dutchess County Regional Chamber of Commerce, where he serves as leader and main instructor to teach leadership skills to small business and non-profit executives.
LJ leads all things marketing, sales, and customer success. She is our go-to-market architect, skilled at creating breakthroughs in thinking, in capability, and in stakeholder commitment, that builds and sustains prosperous results and delights our end clients.
LJ is a trusted leader, agile designer and innovator, go-to-market architect, brand steward, and marketing and customer success expert. She is skilled at creating breakthroughs in thinking, in capability, and in stakeholder commitment, that builds and sustains prosperous results. Prior to joining PotentiaMetrics, LJ served as CEO of the AND group, a boutique consultancy she founded in 2004, where she and her team delivered results for entities spanning the healthcare ecosystem including providers, payers, health IT vendors, clinical analytics, med-tech, as well as, consumer and retail health and wellness care. Prior to the AND group, LJ enjoyed a 17-year progressive career at Procter & Gamble where she held leadership positions in marketing, strategy, insights, customer development, and supply chain innovation. Since 2018, LJ has served on the Board of iDE, a global non-profit applying human centered design in ‘powering entrepreneurs to end poverty’.
Chris is responsible for all things data. He leads Capire360’s model development, architecture, and data management.
Chris is a statistician with extensive experience with the intersection of machine learning and oncology building statistical models. He is highly skilled in data science, statistics and programming, with a vast experience and expertise in data science and biostatistics in both the healthcare and IT industries. For the better part of a decade he served as an independent statistical consultant in the IT and medical industries.
His previous roles include data scientist at HP and Senior Biostatistician for University of Texas Health Science Center San Antonio.
Sandra acts as senior advisor for payor and provider markets.
She retired in 2020 as Group President, BJC HealthCare, and the President of BJC HealthCare‘s ACO, LLC. She also established and served as the senior executive of BJC Collaborative LLC, an organization of seven Midwest regional health systems.
Her professional career includes serving as President & CEO of UniCare Inc., a WellPoint company, and as President, COO & CFO, RightChoice Managed Care, Inc. Prior to her roles with RightChoice, she spent 12 years with Price Waterhouse.
George Lundberg, MS, MD, ScD (hon), is an American board-certified pathologist, speaker, writer, and editor. He served as Editor in Chief of the Journal of the American Medical Association (JAMA) from 1982 to 1999 and is currently the Editor in Chief of Cancer Commons, Editor at Large at Medscape, and a Clinical Professor of Pathology at Northwestern University. He is also President and Board Chair of The Lundberg Institute. Dr. Lundberg has held leadership roles, including President of the American Society for Clinical Pathology, and was a professor at USC, UC Davis, Harvard, and Stanford. He is a member of the National Academy of Medicine and frequently lectures and appears on radio, tv, podcasts, and webcasts.
In 1999, Dr. Gunaratne joined the International Human Genome Project, contributing to the sequencing and annotation of Human Chromosomes 3, 12, and X. In 2000, she became Director of gene (cDNA) sequencing at the Baylor Human Genome Sequencing Center. In 2006, she joined the University of Houston and established a functional genomics platform to identify genetic signatures that predict genome responses to microRNAs and drugs. Collaborating with teams from Baylor College of Medicine and MD Anderson, she pioneered methods for discovering tumor suppressor microRNAs for various cancers. Her work also defined microRNA-regulated gene signatures for personalized cancer treatments.
Dr. Papagikos is a radiation oncologist in Wilmington, North Carolina specializing in the management of lung and prostate cancer. He is very committed to offering and conducting high-quality clinical cancer research in the community setting and underserved populations through physician initiated and national cooperative group studies. He is affiliated with the New Hanover Regional Medical Center and serves as the Director of the Multidisciplinary Lung Program. He received his medical degree and residency training from Wake Forest School of Medicine.
Dr. Heinlen is a board-certified urologist with fellowship training in Urologic Oncology and minimally invasive surgery, specializing in prostate and kidney cancer. Dr. Heinlen completed medical training and a urology residency at the University of Oklahoma, followed by training at the City of Hope National Cancer Center in Los Angeles. He is focused on improving physician-patient interactions for better outcomes, with an emphasis on cost-efficiency, patient-centered care, and evidence-based practice.
Currently serving as Medical Director for the Southern Illinois Division of HSHS Medical Group, Dr. Farmer has over twenty years of experience in family medicine. Dr. Farmer attended Southern Illinois University School of Medicine and completed a family practice residency at Deaconess Hospital in Evansville, Indiana.
Dr. Juknis has over twenty years of experience practicing nephrology and internal medicine. Dr. Juknis graduated medical school at Kaunas Medical Institute and completed a residency at Brown University School of Medicine in Providence, Rhode Island. He went on to serve as a fellow at the University of Minnesota Minneapolis.
Dr. Heinlen is a board-certified urologist with fellowship training in Urologic Oncology and minimally invasive surgery. He specializes in the treatment of urologic cancers, with a particular focus on prostate and kidney cancer. Dr. Heinlen pursued medical training at the University of Oklahoma and continued on in urology residency in Oklahoma. He then trained at the City of Hope National Cancer Center in Los Angeles.
Dr. Fleming is a founding member and president of Tejas Anesthesia in San Antonio, Texas. A graduate of Washington University in St. Louis, Dr. Fleming completed his medical training at Baylor College of Medicine, and residency at UT Health Center in San Antonio. Dr. Fleming is a Diplomate of the American Board of Anesthesiology and belongs to the San Antonio Division of the American Board of Anesthesiology.
Dr. Theodoro is a co-developer of the company’s analytics products for cardiac surgery. Dr. Theodoro brings substantial clinical and cardiac surgery practice management expertise. Dr. Theodoro is a practicing cardiothoracic surgeon, chief of cardiac surgery for one of the largest heart surgery programs in the Midwest at SSM Hospital System, St. Louis and president of a medical service business. He has broad experience in program development, team integration, and contract negotiations. Dr. Theodoro completed Cardiothoracic Surgery training at The Mayo Clinic in Rochester, Minnesota. He finished General Surgery training at Washington University in St. Louis and the University of Pennsylvania, Philadelphia.
Dr. Cox trained in Cardiothoracic Surgery under Dr. David Sabiston at Duke University, where he served as an Assistant and then Associate Professor. He later became the first Evarts A. Graham Professor of Surgery and Chief of Cardiothoracic Surgery at Washington University School of Medicine and Barnes Hospital, a position he held for 14 years. He retired in 2000 as Chairman of Cardiothoracic Surgery at Georgetown University Medical Center and became Emeritus Professor at Washington University in 2006. Dr. Cox has held leadership roles, including President of the American Association for Thoracic Surgery, and is best known for developing the Cox-Maze Procedure, the gold standard for treating atrial fibrillation.